SynCore Biotechnology Co Ltd (4192) — Strategic Asset Allocation Index
SynCore Biotechnology Co Ltd (4192) has a Strategic Asset Allocation Index of 5.9% as of December 2022. Strategic assets (PP&E of NT$14.81 Million plus long-term investments of NT$-) total NT$14.81 Million, measured against net assets of NT$249.01 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
SynCore Biotechnology Co Ltd Strategic Asset Allocation Index (2015–2022)
This chart shows how SynCore Biotechnology Co Ltd's Strategic Asset Allocation Index has evolved across 8 annual periods from 2015 to 2022. As of December 2022, the index stands at 5.9%, representing strategic assets of NT$14.81 Million against net assets of NT$249.01 Million TWD. Explore SynCore Biotechnology Co Ltd (4192) cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for SynCore Biotechnology Co Ltd (2015–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for SynCore Biotechnology Co Ltd from 2015 to 2022, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of SynCore Biotechnology Co Ltd.
| Year | SAAI | Strategic Assets (TWD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 5.9% | NT$14.81 Million | NT$14.81 Million | NT$- | NT$249.01 Million | ▲ +3.4 pp |
| 2021 | 2.5% | NT$11.12 Million | NT$11.12 Million | NT$- | NT$442.92 Million | ▼ -2.5 pp |
| 2020 | 5.0% | NT$27.83 Million | NT$27.83 Million | NT$- | NT$560.58 Million | ▼ -7.1 pp |
| 2019 | 12.0% | NT$73.56 Million | NT$43.17 Million | NT$30.39 Million | NT$612.03 Million | ▲ +1.9 pp |
| 2018 | 10.1% | NT$71.49 Million | NT$12.62 Million | NT$58.87 Million | NT$706.70 Million | ▼ -6.6 pp |
| 2017 | 16.7% | NT$120.45 Million | NT$17.80 Million | NT$102.65 Million | NT$720.61 Million | ▲ +5.9 pp |
| 2016 | 10.8% | NT$104.03 Million | NT$13.60 Million | NT$90.44 Million | NT$966.36 Million | ▼ -19.7 pp |
| 2015 | 30.4% | NT$256.57 Million | NT$18.24 Million | NT$238.34 Million | NT$842.81 Million | — |